Literature DB >> 17258370

Altered HDAC5 and CREB mRNA expressions in the peripheral leukocytes of major depression.

Jun-Ichi Iga1, Shu-Ichi Ueno, Ken Yamauchi, Shusuke Numata, Sawako Kinouchi, Sumiko Tayoshi-Shibuya, Hongwei Song, Tetsuro Ohmori.   

Abstract

BACKGROUND: Gene expressions of the peripheral leukocytes in depressive patients might reflect the systemic dysfunction of major depression. We determined mRNA expression levels of Histone deacetylase 5 (HDAC5) gene and cyclic AMP response element-binding protein 1 (CREB) gene in the leukocyte of depressive patients. HDAC5 and CREB are reported to be important targets of antidepressants, the latter being located in the downstream of the former in lymphocyte calcium signaling.
METHODS: 25 patients with major depression and 25 age- and sex-matched healthy controls were included in this study. Twenty patients were able to be followed up until the 8 week-treatment. The mRNA levels were determined by a quantitative RT-PCR method. RESULT: Levels of HDAC5 and CREB mRNA were significantly higher in drug-free depressive patients than those of controls and the higher mRNA levels decreased to control levels after 8-week paroxetine treatment. There were positive correlation between levels of HDAC5 and CREB.
CONCLUSION: Our results suggest the alteration of HDAC5 and CREB gene expression in the systemic pathophysiology of major depression.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17258370     DOI: 10.1016/j.pnpbp.2006.12.014

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  33 in total

Review 1.  Genetic variation in the epigenetic machinery and mental health.

Authors:  Chris Murgatroyd; Dietmar Spengler
Journal:  Curr Psychiatry Rep       Date:  2012-04       Impact factor: 5.285

2.  Cyclic-AMP response element binding protein (CREB) in the neutrophils of depressed patients.

Authors:  Xinguo Ren; Yogesh Dwivedi; Amal C Mondal; Ghanshyam N Pandey
Journal:  Psychiatry Res       Date:  2010-05-23       Impact factor: 3.222

Review 3.  Epigenetics of the depressed brain: role of histone acetylation and methylation.

Authors:  HaoSheng Sun; Pamela J Kennedy; Eric J Nestler
Journal:  Neuropsychopharmacology       Date:  2012-06-13       Impact factor: 7.853

4.  Transcriptomic predictors of inflammation-induced depressed mood.

Authors:  Joshua Hyong-Jin Cho; Michael R Irwin; Naomi I Eisenberger; Donald M Lamkin; Steve W Cole
Journal:  Neuropsychopharmacology       Date:  2019-01-14       Impact factor: 7.853

Review 5.  Gene expression studies in major depression.

Authors:  Divya Mehta; Andreas Menke; Elisabeth B Binder
Journal:  Curr Psychiatry Rep       Date:  2010-04       Impact factor: 5.285

Review 6.  Biomarkers to predict antidepressant response.

Authors:  Andrew F Leuchter; Ian A Cook; Steven P Hamilton; Katherine L Narr; Arthur Toga; Aimee M Hunter; Kym Faull; Julian Whitelegge; Anne M Andrews; Joseph Loo; Baldwin Way; Stanley F Nelson; Steven Horvath; Barry D Lebowitz
Journal:  Curr Psychiatry Rep       Date:  2010-12       Impact factor: 5.285

Review 7.  Epigenetic mechanisms in mood disorders: targeting neuroplasticity.

Authors:  D M Fass; F A Schroeder; R H Perlis; S J Haggarty
Journal:  Neuroscience       Date:  2013-01-30       Impact factor: 3.590

8.  Hippocampal HDAC4 contributes to postnatal fluoxetine-evoked depression-like behavior.

Authors:  Ambalika Sarkar; Parul Chachra; Pamela Kennedy; Catherine J Pena; Lynette A Desouza; Eric J Nestler; Vidita A Vaidya
Journal:  Neuropsychopharmacology       Date:  2014-03-25       Impact factor: 7.853

9.  Association study of CREB1 with Major Depressive Disorder and related phenotypes.

Authors:  John M Hettema; Seon-Sook An; Edwin J C G van den Oord; Michael C Neale; Kenneth S Kendler; Xiangning Chen
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2009-12-05       Impact factor: 3.568

10.  The Molecular Basis of Depression: Implications of Sex-Related Differences in Epigenetic Regulation.

Authors:  Ayako Kawatake-Kuno; Toshiya Murai; Shusaku Uchida
Journal:  Front Mol Neurosci       Date:  2021-07-01       Impact factor: 5.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.